US Patent Issued to Genentech on Sept. 9 for "Methods and compositions comprising a KRas G12C inhibitor and a VEGF inhibitor for treating solid tumors" (California Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,178, issued on Sept. 9, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Methods and compositions comprising a KRas G12C inhibitor and a VEGF inhibitor for treating solid tumors" was invented by Marie Evangelista (San Francisco), Mark Andrew Merchant (Redwood City, Calif.), Jennifer Lee Schutzman (Belmont, Calif.), Ting-Kun Mark Lin (Mill Valley, Calif.), Stephanie Royer Joo (San Diego), Sandhya Vinayak Mandlekar (Foster City, Calif.) and Stuart G. Lutzker (Walnut Creek, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are combination therapies comprising a KRasG12C inhibitor (e.g. Compound 1 or a pharmaceutically...